One-Pot Synthesis of Ag/ZnO Self-Assembled 3D Hollow Microspheres with Enhanced Photocatalytic Performance

2008 ◽  
Vol 112 (43) ◽  
pp. 16792-16800 ◽  
Author(s):  
Weiwei Lu ◽  
Shuyan Gao ◽  
Jianji Wang
2022 ◽  
Vol 123 ◽  
pp. 111934
Author(s):  
Wenbo Zhao ◽  
Minghua He ◽  
Fengjuan Chen ◽  
Xuekun Jin ◽  
Haiming Duan ◽  
...  

2013 ◽  
Vol 13 (1) ◽  
pp. 657-665 ◽  
Author(s):  
Wei Liu ◽  
Mingliang Wang ◽  
Chunxiang Xu ◽  
Shifu Chen ◽  
Xianliang Fu

2008 ◽  
Vol 128 (12) ◽  
pp. 1980-1984 ◽  
Author(s):  
M. Marandi ◽  
N. Taghavinia ◽  
A. Iraji zad ◽  
S.M. Mahdavi

RSC Advances ◽  
2014 ◽  
Vol 4 (59) ◽  
pp. 31452-31461 ◽  
Author(s):  
Jung Tae Park ◽  
Chang Soo Lee ◽  
Jong Hak Kim

Hierarchical mesoporous SnO2 spheres with a large surface area were synthesized via a facile solvothermal reaction using a graft copolymer template.


2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Ming Wang ◽  
Meiling Huang ◽  
Jianting Wang ◽  
Mingquan Ye ◽  
Yan Deng ◽  
...  

The self-assembled folate-biotin-pullulan (FBP) nanoparticles (NPs) were prepared by facile one-pot synthesis and their physicochemical properties were characterized. The self-assembled FBP NPs were used as an anticancer drug nanocarrier entrapping doxorubicin (DOX) for targeting folate-receptors-overexpressing cancer cells. The identification of prepared NPs to folate-receptor-expressing cancer cells (KB cells) was affirmed by cell viability measurement, folate competition test, and flow cytometric analysis. Compared with the naked DOX and DOX/BP NPs, the DOX/FBP NPs had lower IC50value compared to KB cells as a result of the folate-receptor-mediated endocytosis process. The cytotoxicity of DOX/FBP NPs to KB cells could be inhibited competitively by free folate. The cellular intake pattern of naked DOX and drug-loaded NPs was identified by confocal laser scanning microscopy (CLSM) observation and the higher cellular uptake of drug for DOX/FBP NPs over naked DOX was observed. The prepared FBP NPs had the potential to be used as a powerful carrier to target anticancer drugs to folate-receptor-expressing tumor cells and reduce cytotoxicity to normal tissues.


Sign in / Sign up

Export Citation Format

Share Document